Sohini Das &Amp; Samreen Ahmad

Stories by Sohini Das &Amp; Samreen Ahmad

Serum Institute set to sign deal with Centre for Covishield

Serum Institute set to sign deal with Centre for Covishield

Rediff.com   9 Dec 2020

By January-February, it's expected to have at least 100 million doses for the Indian government, reports Sohini Das.

How Indian pharma bounced back from lockdown lows

How Indian pharma bounced back from lockdown lows

Rediff.com   7 Dec 2020

From rising prescriptions to the pharma sales force back on the field with full vigour and companies finally finding their feet with the digital marketing strategies - Indian drug makers have shown that medicine sales is certainly a sunshine sector.

Covid: How Pfizer plans to resolve cold storage issues in India

Covid: How Pfizer plans to resolve cold storage issues in India

Rediff.com   7 Dec 2020

The company has developed detailed logistical plans and tools to support effective vaccine transport, storage, and temperature monitoring. Sohini Das and Ruchika Chitravanshi report.

Employees or contractors? Gig workers face social code dilemma

Employees or contractors? Gig workers face social code dilemma

Rediff.com   3 Dec 2020

The Code on Social Security, 2020 gives a lot of comfort to gig firms which recognise cab drivers or food delivery executives as 'independent contractors' who directly do business with customers with the help of their digitised platforms.

From January, consumer goods are likely to cost more by 3-5%

From January, consumer goods are likely to cost more by 3-5%

Rediff.com   3 Dec 2020

Prices of all metals - from steel to copper, aluminium, zinc and lead - have shot up by about 5-11 per cent in the past month. Commodity inflation is raising its head, forcing companies to consider price hikes.

How states are preparing for Covid vaccine distribution

How states are preparing for Covid vaccine distribution

Rediff.com   2 Dec 2020

Each state has its own weak areas that need attention. Some states have already identified the gaps and sought the Centre's help. Vinay Umarji, Ishita Ayan Dutt, Samreen Ahmad and Sohini Das report.

India may get first Covid-19 vaccine by February

India may get first Covid-19 vaccine by February

Rediff.com   30 Nov 2020

The government plans to immunise 30 million people in the first phase, starting February, and by July, the target is to vaccinate 250 million people, reports Sohini Das.

Wipro rewrites growth strategy under new chief Thierry Delaporte

Wipro rewrites growth strategy under new chief Thierry Delaporte

Rediff.com   27 Nov 2020

Under the new model, the IT services firm will replace the current structure of its various strategic business units, service lines and geographies with four strategic market units and two global business lines.

Indian Immunologicals to set up new vaccine plant, raise capacity by 35%

Indian Immunologicals to set up new vaccine plant, raise capacity by 35%

Rediff.com   26 Nov 2020

The company has a pipeline of viral vaccines including Zika, dengue, varicella, as well as a potential Covid-19 inoculation.

WFH rules simplified! More jobs for small town India

WFH rules simplified! More jobs for small town India

Rediff.com   23 Nov 2020

Tier-II and tier-III towns have a reason to rejoice.

Byju's raises $200 mn in fresh funding; valuation surges to $12 bn

Byju's raises $200 mn in fresh funding; valuation surges to $12 bn

Rediff.com   23 Nov 2020

While BlackRock is an existing investor in Byju's, T Rowe joined as a new investor.

PUBG to return to India with new game, $100 mn investment, better security

PUBG to return to India with new game, $100 mn investment, better security

Rediff.com   13 Nov 2020

The company is also planning to create an Indian subsidiary to enhance communications and services with players for which it will hire over 100 employees specialising in business, e-sports, and game development.

Serum Institute to keep 200 mn doses of Covid vaccine ready by Jan

Serum Institute to keep 200 mn doses of Covid vaccine ready by Jan

Rediff.com   13 Nov 2020

'SII has started stockpiling the vaccine and now has roughly 40 million doses ready. It is using some of the capacities it had for under development products for the COVID-19 vaccine and by January we will have a capacity to make 100 million doses per month and a stockpile of 200 million doses.'

Pandemic pushes up demand for CT scanners; firms gear up to meet surge

Pandemic pushes up demand for CT scanners; firms gear up to meet surge

Rediff.com   4 Nov 2020

Siemens Healthineers, one of the largest manufacturers of made-in-India CT scanners, has sold 80-100 such machines in the last 45 days. The medical technology firm typically sells 250 machines in a year.

How start-ups are helping kirana stores go digital to manage business

How start-ups are helping kirana stores go digital to manage business

Rediff.com   4 Nov 2020

Start-ups such as Max Wholesale, Jumbotail and ShopKirana are helping them place orders, maintain inventory, optimise delivery routes and make payments, all digitally.

Bharat Biotech starts Covaxin's at-risk manufacture

Bharat Biotech starts Covaxin's at-risk manufacture

Rediff.com   2 Nov 2020

The first vaccine candidate will be an intra-muscular one, followed by intra-dermal and nasal ones, depending on test results.

How Indus, the Made in India app store, took wing

How Indus, the Made in India app store, took wing

Rediff.com   29 Oct 2020

The content discovery platform designed to help you discover content and services in the language of your choice recently turned profitable. It has delivered 1 billion application installs and updates in the past 12 months, says Samreen Ahmad.

Looking to go omnichannel, BigBasket may seal deal with Tatas

Looking to go omnichannel, BigBasket may seal deal with Tatas

Rediff.com   29 Oct 2020

The competition which BigBasket faces now is with the big three - Amazon, Walmart, and Reliance.

Why Dr Reddy's had to shut all its units

Why Dr Reddy's had to shut all its units

Rediff.com   25 Oct 2020

Security breach came days after the firm got approval to conduct trials for Covid-19 vaccine candidate Sputnik V.

Covid-19 impact: Low interest loans likely for vaccine companies

Covid-19 impact: Low interest loans likely for vaccine companies

Rediff.com   10 Oct 2020

While there has been no commitment from the government on the procurement of vaccines, initial volumes, or distribution plans, there is a likelihood that the low interest loans may be made available to these players only when the time to scale up manufacturing arises.